Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (441-450 of 461) with videos related to

Pageof 47
Sort By:
Journal of Psychiatric Research|March 28, 2025
Prediction of postoperative delirium by blood metabolome analysisNaohiro Arai, Yuki Sugiura, Shinichiro Nakajima, et al.
Molecular Psychiatry|September 29, 2021
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of <sup>1</sup>H-magnetic resonance spectroscopy studiesTomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry|April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatmentMasataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
The Lancet. Psychiatry|April 3, 2025
INTEGRATE: international guidelines for the algorithmic treatment of schizophreniaRobert A McCutcheon, Toby Pillinger, Ioana Varvari, et al.
The Lancet. Psychiatry|July 20, 2020
How mental health care should change as a consequence of the COVID-19 pandemicCarmen Moreno, Til Wykes, Silvana Galderisi, et al.
Journal of Neuro-Oncology|April 13, 2023
Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study GroupShinji Yamashita, Hideo Takeshima, Nobuhiro Hata, et al.
Neuropsychiatric Disease and Treatment|October 22, 2013
An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophreniaJinichi Hirano, Koichiro Watanabe, Takefumi Suzuki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2025
Diverse tau pathologies in late-life mood disorders revealed by PET and autopsy assaysShin Kurose, Sho Moriguchi, Manabu Kubota, et al.
Journal of Alzheimer'S Disease : JAD|November 12, 2024
Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomographyHisaomi Suzuki, Kenji Tagai, Maiko Ono, et al.
Cell Reports. Medicine|April 20, 2023
Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsyTsuyoshi Eiro, Tomoyuki Miyazaki, Mai Hatano, et al.
Pageof 47

Showing results (441-450 of 461) with videos related to

Sort By:
Pageof 47
Journal of Psychiatric Research|March 28, 2025
Prediction of postoperative delirium by blood metabolome analysisNaohiro Arai, Yuki Sugiura, Shinichiro Nakajima, et al.
Molecular Psychiatry|September 29, 2021
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of <sup>1</sup>H-magnetic resonance spectroscopy studiesTomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, et al.
Molecular Psychiatry|April 21, 2022
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatmentMasataka Wada, Yoshihiro Noda, Yusuke Iwata, et al.
The Lancet. Psychiatry|April 3, 2025
INTEGRATE: international guidelines for the algorithmic treatment of schizophreniaRobert A McCutcheon, Toby Pillinger, Ioana Varvari, et al.
The Lancet. Psychiatry|July 20, 2020
How mental health care should change as a consequence of the COVID-19 pandemicCarmen Moreno, Til Wykes, Silvana Galderisi, et al.
Journal of Neuro-Oncology|April 13, 2023
Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study GroupShinji Yamashita, Hideo Takeshima, Nobuhiro Hata, et al.
Neuropsychiatric Disease and Treatment|October 22, 2013
An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophreniaJinichi Hirano, Koichiro Watanabe, Takefumi Suzuki, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2025
Diverse tau pathologies in late-life mood disorders revealed by PET and autopsy assaysShin Kurose, Sho Moriguchi, Manabu Kubota, et al.
Journal of Alzheimer'S Disease : JAD|November 12, 2024
Distinct tau pathologies in the nucleus basalis of Meynert between early-onset and late-onset Alzheimer's disease patients revealed by positron emission tomographyHisaomi Suzuki, Kenji Tagai, Maiko Ono, et al.
Cell Reports. Medicine|April 20, 2023
Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsyTsuyoshi Eiro, Tomoyuki Miyazaki, Mai Hatano, et al.
Pageof 47